Clinical evidence for synergy between immunotherapy and radiotherapy ( <scp>SITAR</scp> )-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical evidence for synergy between immunotherapy and radiotherapy ( SITAR )

Published:2022-06-14 Issue:6 Volume:66 Page:881-895
ISSN:1754-9477
Container-title:Journal of Medical Imaging and Radiation Oncology
language:en
Short-container-title:J Med Imag Rad Onc

Author:

Gill Suki¹²^ORCID,Nowak Anna K¹²³^ORCID,Bowyer Samantha¹²,Endersby Raelene²⁴^ORCID,Ebert Martin A¹²^ORCID,Cook Alistair²³^ORCID

Affiliation:

1. Sir Charles Gairdner Hospital Nedlands Western Australia Australia

2. University of Western Australia Crawley Western Australia Australia

3. Institute for Respiratory Health Nedlands Western Australia Australia

4. Telethon Kids Institute Nedlands Western Australia Australia

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1754-9485.13441

Reference97 articles.

1. Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma;Stone HB;J Natl Cancer Inst,1979

2. Abscopal effects of radiation therapy: A clinical review for the radiobiologist

3. Enhancing the efficacy of immunotherapy using radiotherapy

4. Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy

5. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global research landscape and trends of cancer radiotherapy plus immunotherapy: A bibliometric analysis;Heliyon;2024-03

2. Integrating novel immunotherapeutic approaches in organ‐preserving therapies for bladder cancer;British Journal of Pharmacology;2024-01-16

3. Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502);European Urology Oncology;2023-10

4. Management of metastatic melanoma in Texas: disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors;BMC Cancer;2023-07-13

5. Systemic Treatments and Molecular Biomarkers for Perivascular Epithelioid Cell Tumors: A Single-institution Retrospective Analysis;Cancer Research Communications;2023-07-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3